Longitudinal Positron Emission Tomography of Dopamine Synthesis in Subjects with GBA1 Mutations.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32030791.
- Also identified by DOI 10.1002/ana.25692.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mutations in GBA1, the gene mutated in Gaucher disease, are a common genetic risk factor for Parkinson disease, although the penetrance is low. We performed [<sup>18</sup> F]-fluorodopa positron emission tomography studies of 57 homozygous and heterozygous GBA1 mutation carriers (15 with parkinsonism) and 98 controls looking for early indications of dopamine loss using voxelwise analyses to identify group differences in striatal [<sup>18</sup> F]-fluorodopa uptake (K<sub>i</sub> ). Forty-eight subjects were followed longitudinally. Cross-sectional and longitudinal comparisons of K<sub>i</sub> and K<sub>i</sub> change found significant effects of Parkinson disease. However, at baseline and over time, striatal [<sup>18</sup> F]-fluorodopa uptake in mutation carriers without parkinsonism did not significantly differ from controls. ANN NEUROL 2020;87:652-657.
Medical subject headings
- Dopamine
- Gaucher Disease
- Neostriatum
- Parkinson Disease